Joshua Willey is a Neurology physician affiliated with Columbia University Irving Medical Center. OpenAlex indexes 348 publications with 40,540 citations (h-index 42). By OpenAlex citation count, this profile ranks in the top 5% of Neurology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
710 W 168th St
New York, NY 100323726
Telephone
212-305-1710Registry record last updated 1 Jun 2012.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- BrioHealth Solutions, Inc.Program year20255 payments
- Abbott LaboratoriesProgram year20252 payments
- Abbott LaboratoriesProgram year20235 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
49%Gabapentinoids24.7%Pregabalin60%Gabapentin40%Part D<11 patientsOther antiepileptics13.9%Levetiracetam56%Lacosamide44%Part D<11 patients+ 1 more class in this area
Cardiovascular
30.4%Statin24.2%Rosuvastatin Calcium51%Atorvastatin Calcium49%Part D<11 patientsCalcium channel blocker6.2%Verapamil Sr100%Part D<11 patientsBlood & clotting
20.6%Factor Xa inhibitor10.8%Eliquis100%Part D<11 patientsP2Y12 inhibitor9.8%Clopidogrel100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
3 NIH research awards on record, funded 2011–2025 per NIH RePORTER. The latest:
- Neurovascular Consequences of Non-Pulsatile Flow from Left Ventricular Assist Devices
Columbia University Health Sciences
FY2025$503,911R01NS121364 - Neurovascular Consequences of Non-Pulsatile Flow from Left Ventricular Assist Devices
Columbia University Health Sciences
FY2024$520,710R01NS121364 - Neurovascular Consequences of Non-Pulsatile Flow from Left Ventricular Assist Devices
Columbia University Health Sciences
FY2023$511,536R01NS121364
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Decline in stroke alerts and hospitalisations during the COVID-19 pandemic
Stroke and Vascular Neurology
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Stanley Fahn, MD
Columbia University Irving Medical Center
Rebecca Hahn, MD
Columbia University Irving Medical Center
Susheel Kodali, MD
Columbia University Irving Medical Center
Ronald Wapner, MD
Columbia University Irving Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”